CHIME FINANCIAL ($CHYM) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.12 per share, beating estimates of -$0.16 by $0.04. The company also reported revenue of $596,360,000, beating estimates of $589,589,498 by $6,770,502.
Stock price change since market close: +6.68%
You can see Quiver Quantitative's $CHYM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHIME FINANCIAL Insider Trading Activity
CHIME FINANCIAL insiders have traded $CHYM stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:
- JAMES FEUILLE has made 0 purchases and 3 sales selling 183,397 shares for an estimated $4,957,755.
- AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 2 sales selling 84,589 shares for an estimated $1,704,972.
- CHRISTOPHER R BRITT (Chief Executive Officer) sold 50,000 shares for an estimated $1,402,825
- ADAM B FRANKEL (General Counsel) has made 0 purchases and 6 sales selling 13,142 shares for an estimated $333,745.
- MATTHEW S NEWCOMB (Chief Financial Officer) sold 10,000 shares for an estimated $280,109
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CHIME FINANCIAL Hedge Fund Activity
We have seen 144 institutional investors add shares of CHIME FINANCIAL stock to their portfolio, and 103 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FORERUNNER VENTURES MANAGEMENT, LLC added 9,031,107 shares (+inf%) to their portfolio in Q4 2025, for an estimated $227,312,963
- ASHTON THOMAS PRIVATE WEALTH, LLC added 5,128,770 shares (+inf%) to their portfolio in Q4 2025, for an estimated $129,091,140
- CITADEL ADVISORS LLC added 4,249,643 shares (+178.3%) to their portfolio in Q4 2025, for an estimated $106,963,514
- POINT72 ASSET MANAGEMENT, L.P. added 3,574,654 shares (+353.1%) to their portfolio in Q4 2025, for an estimated $89,974,041
- ICONIQ CAPITAL, LLC removed 2,992,314 shares (-19.9%) from their portfolio in Q4 2025, for an estimated $75,316,543
- IEQ CAPITAL, LLC added 2,312,846 shares (+inf%) to their portfolio in Q4 2025, for an estimated $58,214,333
- GENERAL ATLANTIC, L.P. added 2,050,923 shares (+10.7%) to their portfolio in Q4 2025, for an estimated $51,621,731
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CHIME FINANCIAL Analyst Ratings
Wall Street analysts have issued reports on $CHYM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 01/06/2026
- B. Riley Securities issued a "Buy" rating on 12/11/2025
- JP Morgan issued a "Overweight" rating on 11/06/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 10/01/2025
To track analyst ratings and price targets for CHIME FINANCIAL, check out Quiver Quantitative's $CHYM forecast page.
CHIME FINANCIAL Price Targets
Multiple analysts have issued price targets for $CHYM recently. We have seen 9 analysts offer price targets for $CHYM in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Harry Bartlett from Rothschild & Co set a target price of $29.0 on 01/26/2026
- Will Nance from Goldman Sachs set a target price of $30.0 on 01/06/2026
- Hal Goetsch from B. Riley Securities set a target price of $35.0 on 12/11/2025
- Tien-Tsin Huang from JP Morgan set a target price of $34.0 on 11/06/2025
- Patrick Moley from Piper Sandler set a target price of $30.0 on 11/06/2025
- Timothy Chiodo from UBS set a target price of $24.0 on 11/06/2025
- Trevor Williams from Jefferies set a target price of $17.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.